ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Search for New NCI director focuses On California; Possibilities Include Korn, Beahrs, Gale, Others

September 23, 1988

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

Abstracts Deadline For Cancer Congress Extended To Dec. 31

December 13, 1985

Stanford Group Working To Build ‘Superhighway’ To Synthesis Of Taxol

May 15, 1992

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988